Home / Brands / Dragon Pharma / Dragon Pharma Sermorelin 5 mg GHRH 1-29 Research Peptide Vial
International Available Domestic
Dragon Pharma Sermorelin 5 mg GHRH 1-29 Research Peptide Vial
Dragon Pharma

Dragon Pharma Sermorelin 5 mg GHRH 1-29 Research Peptide Vial

Injection · 5 mg · vial

In stock · ships within 24h Out of stock
$45.00

Dragon Pharma Sermorelin is a 5 mg lyophilized vial of the GHRH(1-29) fragment, the shortest natural form of the releasing hormone. It tells the pituitary to output its own growth hormone in a pulse, and it clears quickly enough to need daily use. Research material only.

GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. Sermorelin for sale with U.S. domestic and international shipping.

Shipping Not available in this combination
1
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Dragon Pharma Sermorelin 5 mg GHRH 1-29 Vial

Sermorelin is the first 29 amino acids of growth hormone releasing hormone, the piece that carries the biological activity, and it was once sold in pharmacies as Geref for diagnosing growth hormone deficiency. It works upstream: instead of supplying growth hormone, it asks the pituitary to release its own. That makes the response self-limiting in a way injections of the hormone are not, and it is the reason this fragment still appears in research catalogues.

  • 5 mg lyophilized powder per vial, one pack option
  • GHRH(1-29) fragment, ancestor of the longer analogues
  • GMP-manufactured and HPLC-verified, COA per batch
  • U.S. domestic and international shipping options

How Sermorelin Works

The fragment binds GHRH receptors on pituitary cells and triggers a pulse of growth hormone, which in turn raises IGF-1. Its action is very short: the parent GHRH(1-29) amide disappeared with a half-life of 6.2 minutes in rat intravenous work, and no human figure is established, though vendor texts quote 10 to 20 minutes. That brevity is the reason the longer analogues such as Tesamorelin and CJC-1295 DAC exist, and it is also why sermorelin is described as a daily peptide.

Reconstitution & Research Use

Add bacteriostatic water down the glass wall and swirl, do not shake. Five milligrams with 2 ml gives 2.5 mg/ml, so 0.1 ml carries 250 mcg and reads as 10 units on a U-100 insulin syringe. Vendor material describes a subcutaneous injection at night on an empty stomach, several days a week rather than continuously, and often next to a ghrelin peptide such as Ipamorelin or in the ready-made Ipamorelin / Tesamorelin vial. Class side effects reported for the GHRH peptides are injection-site reactions, flushing, headache, fluid retention and joint discomfort.

Quality & Authenticity

Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Keep the sealed powder at 2-8 C and the mixed solution refrigerated for short-term use.

For laboratory research only. Consult a healthcare professional before use.

Specifications

BrandDragon Pharma
Active SubstanceSermorelin (GHRH 1-29)
Dosage5 mg per vial
Package1 lyophilized vial
FormFreeze-dried powder, requires reconstitution
Drug ClassResearch peptide, GHRH analogue
ManufacturingGMP-certified
TestingHPLC per batch, COA on file
ShippingU.S. domestic and international

Stacks

Sermorelin Nightly Course

Five milligrams with 2 ml gives 250 mcg per 10 units, and vendor material describes a nightly subcutaneous injection on an empty stomach, several days a week.

Outcome: a short nightly pulse of the user's own growth hormone rather than an external supply.

Sermorelin With A Ghrelin Peptide

Because the fragment clears in minutes, community logs pair it with a ghrelin arm such as GHRP-2 5 mg or the premixed Ipamorelin / Tesamorelin 10 mg.

Outcome: two receptor paths on one schedule, with no trial of the combination.

Moving Up To A Longer Analogue

Users who want fewer injections switch to Tesamorelin 5 mg or to the albumin-bound CJC-1295 DAC 5 mg.

Outcome: the same GHRH route with a longer presence, and the same research-only status.

FAQ

Before you ask

Questions, answered

Sermorelin is the GHRH(1-29) fragment, the active first 29 amino acids of growth hormone releasing hormone, and it was previously marketed in pharmacies as Geref for growth hormone testing. It stimulates the pituitary to release the body's own growth hormone, so the signal it creates is a pulse rather than a constant level. There is no current human approval and the vial is sold as research material.

The measured figure comes from rat intravenous work on the parent GHRH(1-29) amide, at 6.2 minutes, and no human half-life has been established. Vendor descriptions quote 10 to 20 minutes, which is a practical range rather than a measurement. Either way the peptide is short-lived, so daily or nightly timing is the convention instead of weekly dosing.

Aim the bacteriostatic water at the inside wall, swirl and do not shake. Five milligrams with 2 ml gives 2.5 mg/ml, so 0.1 ml carries 250 mcg, which is 10 units on a U-100 insulin syringe. One millilitre instead of two doubles that to 500 mcg per 10 units. Keep the powder at 2-8 C and the mixed solution refrigerated, and do not refreeze it.

The GHRH peptides are described with injection-site reactions, flushing and headache after a dose, plus joint or muscle discomfort and fluid retention in the class. No hepatic problems are documented for sermorelin. It is named directly in WADA class S2, which covers growth hormone releasing factors and prohibits them at all times, so any use is a doping violation for a tested athlete.

The 5 mg vial is listed as research material with U.S. domestic and international shipping, and price and stock are shown against the option selector on this page. The peptide is supplied for laboratory work, so it is sold with the same handling expectations as any other lyophilized research product, including cold storage from arrival.

No reviews yet

Be the first to share your experience with Dragon Pharma Sermorelin 5 mg GHRH 1-29 Research Peptide Vial

Log in to write a review